Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Newsletter
Re-importing Drugs, TARP for Small Business and Palin on ClimateGate
The Senate health care debate stalls on the question of whether to permit the re-importation of drugs from countries with price controls. President Obama announces…
Study
Congressional Misdiagnosis
Why Repealing McCarran-Ferguson Will Harm Competition in Health Insurance Markets…
News Release
Stripping Insurers’ Antitrust Exemption is a Congressional Misdiagnosis, New Report Shows
Stripping Insurers’ Antitrust Exemption is a Congressional Misdiagnosis, New Report Shows McCarran-Ferguson Repeal Won’t Help Consumers, May Hurt Competition Washington, D.C., December 8,…
Newsletter
Sarbanes-Oxley in Court, Swine Flu Peaks and Trade Deficits in Perspective
The U.S. Supreme Court hears arguments challenging the legitimacy of the Sarbanes-Oxley corporate accounting law. Swine flu infections have peaked and are declining, according to…
Overlawyered
FDA Raw Oyster Ban
Newsletter
Online Gambling, Heath Care in the Senate and the Victims of Cap and Trade
Controversial online gambling regulations get delayed until mid-2010. Senators prepare for a long and possibly bitter debate over major health care legislation. The Leader of…